Core Insights - The medical device ETF (159873) has shown significant trading activity with a turnover of 10.71% and a transaction volume of 12.03 million yuan as of January 6, 2026, indicating a vibrant market [1] - The ETF has experienced substantial growth, with an increase of 26.77 million yuan over the past year and a rise of 23 million units in the last three months [1] - Neuralink is set to begin large-scale production of brain-computer interface technology, marking a significant advancement in the industry [1] Product Highlights - The medical device ETF (159873) closely tracks the CSI All-Share Healthcare Equipment and Services Index, which selects listed companies related to healthcare to reflect the overall performance of this sector [1] Industry Trends - The brain-computer interface industry is witnessing a surge in clinical advancements and diverse technological approaches, leading to a competitive landscape [2] - According to Open Source Securities, the brain-computer interface sector is in a high-growth phase driven by technological breakthroughs, policy support, and collaborative robotics ecosystems [2] - The global brain-computer interface market is projected to reach approximately $12.4 billion by 2034, with a CAGR of 17% from 2025 to 2034 [2]

◼ 建议关注国内在脑机接口领域布局的企业，如翔宇医疗、美好医疗、创新 医疗、三博脑科、爱朋医疗等标的。 评级面临的主要风险 ◼ 脑机接口行业仍然处于发展初期，行业发展仍具备较大的不确定性；相关 公司的产品多处于临床阶段，产品具备临床失败的风险。 医药生物 | 证券研究报告 — 行业点评 2026 年 1 月 6 日 强于大市 脑机接口市场热度较高，密 切关注后续产业进展 事件：近期，美国企业家马斯克在社交媒体上表示，其旗下的脑机接口公司 Neuralink 计划于 2026 年开始对脑机接口设备进行"大规模生产"，并转向 "更加精简和几乎完全自动化的外科手术流程"。在此背景下，国内脑机接 口相关公司获得较高的市场关注度。 支撑评级的要点 投资建议 相关研究报告 《医药行业 2026 年策略报告》20251205 《从"十五五"规划看医药行业未来发展机会》 20251029 《医保局明确集采反内卷，关注医药板块重估 机会》20250729 中银国际证券股份有限公司 具备证券投资咨询业务资格 医药生物 证券分析师：刘恩阳 enyang.liu@bocichina.com 证券投资咨询业务证书编号：S1300523 ...

Group 1 - The core viewpoint of the news is that Kangtong Medical has shown significant stock performance with a 14.16% increase on January 5, 2023, and a trading volume of 218 million yuan [1] - As of January 5, 2023, Kangtong Medical's financing balance reached 42.45 million yuan, accounting for 2.66% of its market capitalization, indicating a high level of financing activity compared to the past year [1] - The company primarily engages in providing medical gas systems and clean operating room solutions, with its main revenue sources being clean equipment and systems (55.69%) and medical gas equipment and systems (37.30%) [1] Group 2 - As of December 31, 2022, the number of shareholders for Kangtong Medical was 7,415, a decrease of 1.64% from the previous period, while the average circulating shares per person increased by 1.67% to 8,501 shares [2] - For the period from January to September 2025, Kangtong Medical reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, a decline of 150.92% [2] - Since its A-share listing, Kangtong Medical has distributed a total of 48.997 million yuan in dividends [3]

Group 1: Medical Technology - The introduction of United Imaging's MRI system in Spain has significantly improved diagnostic efficiency, reducing scan times for lumbar imaging from 25 minutes to 12 minutes and neurological scans from 60 minutes to 30 minutes [14] - The system utilizes AI image reconstruction technology, enhancing image clarity and enabling better diagnosis of conditions that were previously difficult to visualize [14][15] - The implementation of this technology has allowed HM Hospital to increase the number of MRI scans performed daily from fewer than 25 to 40, thereby reducing patient wait times [15] Group 2: Transportation and Mobility - Didi Chuxing's acquisition of the Brazilian 99 platform has integrated AI and big data technologies to enhance local transportation efficiency, making daily life more convenient for residents [16] - The self-developed order distribution system by Didi has improved matching efficiency for drivers and passengers, reducing wait times through real-time analysis of driver locations and service demand [17] - The 99 platform has established a "Sustainable Mobility Alliance" in Brazil, promoting the adoption of electric vehicles and enhancing the operational efficiency of drivers [18] Group 3: Education Technology - iFlytek's AI-based Chinese teaching system has been introduced in Thailand, improving teaching efficiency and student engagement in learning Chinese [19] - The system generates personalized lesson plans and provides real-time feedback on students' pronunciation, significantly increasing student participation in class discussions [20] - Pilot programs in Thai schools have shown improvements in students' pronunciation accuracy, with initial assessments indicating a rise in accuracy rates for both initials and finals [21]

Group 1: Artificial Intelligence in Healthcare - Chinese artificial intelligence technology is becoming more accessible and sustainable, addressing national development concerns and aiding local economic and social development [1] - The introduction of United Imaging's MRI system in Spain significantly reduces diagnosis time, with imaging speed improved from 25 minutes to 12 minutes for lumbar scans and from 1 hour to 30 minutes for neurological scans [3][4] - The new MRI system enhances image quality through AI reconstruction, allowing for better diagnosis of previously unclear areas, thus improving patient outcomes and operational efficiency in hospitals [3][4] Group 2: Transportation and Delivery Innovations - Didi Chuxing's order distribution system in Brazil utilizes real-time data analysis to improve matching efficiency, reducing wait times for passengers and drivers [7] - The 99 platform, acquired by Didi, has integrated AI and big data to enhance user experience and optimize delivery routes, contributing to increased driver income [6][7] - The establishment of the "Sustainable Mobility Alliance" in Brazil aims to promote electric vehicle adoption, with over 30 companies participating, reflecting a commitment to sustainable transportation solutions [8] Group 3: Educational Technology in Language Learning - iFlytek's intelligent teaching system in Thailand enhances Chinese language education by automating lesson preparation and providing real-time feedback on student performance [9][10] - The system has led to a significant increase in student participation, with average speaking instances per class rising from 2 to 12, indicating a shift towards a more student-centered learning approach [11] - iFlytek plans to expand its collaboration with ASEAN countries to further develop localized educational resources and training, aiming to create a more intelligent and inclusive educational ecosystem [11]

1月5日主力资金净流出557.22万元；游资资金净流入428.34万元；散户资金净流入128.88万元。 公司公告汇总 截至2026年1月5日收盘，迈得医疗(688310)报收于15.94元，上涨3.98%，换手率2.72%，成交量4.53万 手，成交额7176.69万元。 当日关注点 交易信息汇总 资金流向 迈得医疗工业设备股份有限公司关于以集中竞价交易方式首次回购公司股份的公告 迈得医疗工业设备股份有限公司于2026年1月5日通过集中竞价交易方式首次回购公司股份127,283股， 占公司总股本的0.0766%。回购价格区间为15.69元/股至15.80元/股，支付资金总额2,004,504.07元（不含 交易费用）。本次回购系基于公司2025年12月30日经股东会审议通过的回购方案，回购资金来源为超募 资金或自有资金，拟用于减少注册资本，回购期限为12个月，回购金额区间为2,000万元至4,000万元， 回购价格上限为24元/股。本次回购符合相关法规及公司方案规定。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 迈得医疗工业设 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ■ 一、回购股份的基本情况 迈得医疗工业设备股份有限公司（以下简称"公司"）于2025年12月11日、2025年12月30日分别召开第五 届董事会第八次会议、2025年第二次临时股东会，审议通过了《关于以集中竞价交易方式回购公司股份 方案的议案》，同意公司以首次公开发行股票超募资金或自有资金通过集中竞价交易方式回购公司已发 行的部分人民币普通股（A股）股票，用于减少公司注册资本，回购金额不低于人民币2,000万元 （含），不超过人民币4,000万元（含），回购价格不超过24元/股（含），回购期限为自股东会审议通 过本次回购股份方案之日起12个月内。具体内容详见公司于2025年12月31日披露在上海证券交易所网站 （www.sse.com.cn）的《迈得医疗工业设备股份有限公司关于以集中竞价交易方式回购股份的回购报告 书》（公告编号：2025-057）。 二、回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第7号一一回购股份》等相 ...

Suspension and Resumption - ChuanYin High-Tech: The stock is suspended as the offer period for the acquisition by China Seed Group has expired [1] Private Placement - Weigao Blood Purification: Plans to issue shares to acquire 100% equity of Weigao Purui at a transaction price of 8.511 billion yuan [2] - Haopeng Technology: Plans to raise no more than 800 million yuan through a private placement for energy storage battery construction projects and steel shell stacked lithium battery projects [2] Equity Transfer and Increase - Tengya Precision: The controlling shareholder intends to transfer 5.7% of shares at a price of 14.47 yuan per share [3] - JinFang Energy: Yang Jianxun and his concerted parties plan to transfer a total of 10.46% of shares [4] - Hengyi Petrochemical: The controlling shareholder and concerted parties adjusted the share buyback price range from no more than 10 yuan per share to no more than 15 yuan per share [4] Daily Operations and External Investments - Fulian Precision: A subsidiary plans to invest a total of 8.7 billion yuan to build a project with an annual production capacity of 500,000 tons of high-end lithium iron phosphate for energy storage [5] - Defu Technology: A wholly-owned subsidiary signed a cooperation intention agreement with a well-known domestic CCL enterprise to supply high-end electronic circuit copper foil products [5] - Tianchen Medical: Signed a strategic cooperation agreement with Inspur Digital Technology (Shanghai) to jointly invest in R&D resources for medical robots [5] - Xusheng Group: Recently received a notification from a North American electric vehicle manufacturer for supplying components, with a project lifecycle of about 8 years and a total sales amount of approximately 7.8 billion yuan [5] - Jinguang Equipment: Plans to invest about 581 million yuan in the construction of the third phase of the complete equipment industrialization project for filtration [7] - Guizhou Tire: Plans to invest 299 million USD in Morocco to build an intelligent manufacturing project for semi-steel radial tires [9] - Zhejiang Mining: Plans to acquire 100% equity of Alaigyr Company, which owns lead-silver mines in Kazakhstan [10] - Feiwo Technology: Recently completed the acquisition of 60% equity in liquid rocket engine component company Xinsai Aerospace [11] - Tianci Materials: Plans to suspend production for maintenance on the 150,000-ton liquid lithium hexafluorophosphate production line at the Longshan North base [12] Performance Changes - Chifeng Gold: Expects a net profit of 3 billion to 3.2 billion yuan in 2025, an increase of approximately 70% to 81% year-on-year [13] - Dingtai High-Tech: Expects a net profit of 410 million to 460 million yuan in 2025, a year-on-year growth of 81% to 103% [13] - China National Materials: Expects a net profit of 1.55 billion to 1.95 billion yuan in 2025, a year-on-year increase of 73.79% to 118.64% [13] - Ugreen Technology: Expects a net profit of 653 million to 733 million yuan in 2025, a year-on-year growth of 41.26% to 58.56% [13] - Huayou Cobalt: Expects a net profit of 5.85 billion to 6.45 billion yuan in 2025, a year-on-year increase of 40.80% to 55.24% [13]

2025年12月19日至21日，首届进博优品交易会（以下简称"小进博"）在国家会展中心（上海）举行。作为进博会在会期 外的延伸，本次活动聚焦优质消费产品，是"共享大市场·出口中国"系列中的重要一环。 在现场，3H馆和4.1H馆内人流如织，汇集60多个国家和地区的700多家企业，打造了一场为期三天的"年末消费嘉年华"。 众多进博会同款新品从展台直达消费现场，让普通观众一站式选购"进博年货"，切实感受开放共赢的市场活力。 首发新品引领消费新浪潮 如果说惠民折扣点燃了消费热情，那么馆内的"进博首发新品汇"则展现了"首发经济"的蓬勃活力。 展台上的巧克力、饼干等多款进口食品前都围满了试吃的市民，不少人一买就是好几袋。"第一天就卖了几百箱，加起来 有七八千袋。"工作人员语气里满是惊喜。 在巴西圣保罗投促局展台，来自南美大陆的风味同样吸引众多观众。"我们的速溶咖啡选用巴西山多士优质咖啡豆，口感 柔和不苦涩。"工作人员手持产品向围观市民演示冲泡方法，"平时68元一盒，现在买3盒送2盒，折算下来一杯黑咖才一 块多钱。"市民王女士听完立刻下单5盒："家里人都爱喝咖啡，这个价格比代购还划算，正好囤着当年货。" 美妆服饰区域更是优 ...

摘要 ： 作为流式细胞样本前处理设备，CytoNexus实现了全封闭操作、自动化流程和即插即用设计等多项创新性突破。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 2025 年 12 月 下旬，江苏卓微生物科技有限公司正式推出流式细胞样本前处理革新性产品 —Cy toNexus 全封闭・全自动・即用型智能系 统。该产品凭借全封闭操作、自动化流程、即插即用设计三大核心突破，直击行业痛点，为临床检验、科研实验、生物制药等领域带来标准 化、高效化的样本前处理解决方案，引发行业关注。 ▉ 直击行业痛点，填补市场空白 当前流式细胞分析的样本前处理环节长期面临多重困境：人工操作需 30-60 分钟 / 样本，批量处理压力大，人力 成本高；手工操作差异导 致 CV 值常超 15%，数据可比性差；开放操作易产生气溶胶，存在交叉污染与职业暴露风险。即便现有自动化设备，也存在价格昂贵、操作 复杂、纯化效率低、样本适应性局限等问题。 Cy toNexus 的推出精准解决了这些痛点，其以 "全封闭、全自动、即用型" 为核心定位，专为流式细胞分析设计，可自动完成裂 ...